The Human Leukocyte Antigen-DR (HLA-DR) molecule presents exogenous antigens to CD4+ T cells, promoting CD40L expression and specific Interferon-γ (IFN-γ) activation on CD4+ T cells, thereby inducing immune responses and contributing to RA development (30, 31). The gene discussed is IFNG; the disease is rheumatoid arthritis.